Company profile
Axovia Therapeutics
Driving gene therapy breakthroughs to develop transformative AAV treatments for patients with ciliopathies like BBS
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- London, England
- LinkedIn followers
- 3,054
- Office locations
- 2
Axovia Therapeutics company summary
Axovia Therapeutics is a company in the Biotechnology Research industry, headquartered in London, England. On LinkedIn the company has around 6 employees and 3,054 followers. The company lists 2 office locations.
What technology does Axovia Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Axovia Therapeutics
Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families and caregivers. Axovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting the most debilitating aspects of the neurological, metabolic and retinal dysfunctions.
Where is Axovia Therapeutics located?
Axovia Therapeutics lists 2 office locations.
Compare companies similar to Axovia Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Axovia Therapeutics axoviatherapeutics.com | Biotechnology Research | 6 | - | London, England |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Axovia Therapeutics
What does Axovia Therapeutics do?
Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families and caregivers. Axovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting the most debilitating aspects of the neurological, metabolic and retinal dysfunctions.
How many employees does Axovia Therapeutics have?
Axovia Therapeutics has around 6 employees on LinkedIn.
Where is Axovia Therapeutics headquartered?
Axovia Therapeutics is headquartered in London, England.
Where does Axovia Therapeutics have offices?
Axovia Therapeutics lists 2 office locations, including London, England SW1Y 5ES, GB; London, England NW1 0NH, GB.
Build a lead list from companies like Axovia Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.